|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.580 HKD | +0.35% |
|
+2.51% | +1.78% |
| 07-29 | CSPC Pharmaceutical Starts Phase 2 Trial of Hypertension Drug | MT |
| 07-29 | CSPC-Licensed Oropharyngeal Cancer Drug Cleared for U.S. Registrational Trial | MT |
Chart calendar CSPC Pharmaceutical Group Limited
Upcoming events on CSPC Pharmaceutical Group Limited
| 2026-08-20 | Earnings release - Q2 2026 |
Past events on CSPC Pharmaceutical Group Limited
| 2026-05-27 | Annual General Meeting | 22:00 |
| 2026-05-26 | Earnings release - Q1 2026 | |
| 2026-05-26 | Board of Directors Meeting | |
| 2026-03-25 | Earnings release - Annual 2025 | |
| 2026-03-24 | Board of Directors Meeting | |
| 2025-11-19 | Earnings release - Q3 2025 | |
| 2025-11-19 | Board of Directors Meeting | |
| 2025-08-21 | Board of Directors Meeting | |
| 2025-08-21 | Earnings release - Q2 2025 |
Past dividends on CSPC Pharmaceutical Group Limited
| 2026-06-24 | Ex-dividend date - 0.15 HKD | 00:00 |
| 2025-10-17 | Ex-dividend date - 0.14 HKD | 00:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million HKD | Released Forecast Spread | 34 175 34 801 -1.8% | 31 046 31 640 -1.88% | 29 533 31 140 -5.16% | 35 696 | 35 175 | 37 540 |
|
EBITDA Million HKD | Released Forecast Spread | 8 615 9 271 -7.08% | 7 547 7 501 0.61% | 7 168 7 696 -6.86% | 12 782 | 9 929 | 10 529 |
|
EBIT Million HKD | Released Forecast Spread | 7 400 8 079 -8.4% | 6 113 6 300 -2.97% | 5 564 6 530 -14.8% | 9 230 | 7 705 | 8 187 |
|
Earnings before Tax (EBT) Million HKD | Released Forecast Spread | 8 030 8 336 -3.68% | 5 971 6 368 -6.24% | 5 460 6 952 -21.46% | 10 020 | 8 581 | 9 361 |
|
Net income Million HKD | Released Forecast Spread | 6 382 6 692 -4.63% | 4 632 5 076 -8.74% | 4 409 5 526 -20.22% | 7 935 | 6 932 | 7 548 |
|
EPS HKD | Released Forecast Spread | 0,54 0,56 -4.57% | 0,39 0,45 -11.84% | 0,39 0,48 -20.24% | 0,72 | 0,62 | 0,67 |
| Announcement Date | 20/03/24 | 28/03/25 | 25/03/26 | - |
Quarterly results
| Fiscal Period | March | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 S1 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 S1 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million HKD | Released Forecast Spread | 6 887 8 015 -14.08% | 6 767 7 159 -5.47% | 7 644 9 362 -18.35% | 6 810 8 446 -19.37% | 14 443 16 255 -11.15% | 7 248 8 043 -9.88% | 6 944 9 273 -25.11% | 7 465 7 533 -0.91% | 10 115 | 15 476 | 8 535 | 8 709 | ||||
|
EBITDA Million HKD | Released Forecast Spread | 2 302 | 7 607 | 1 451 | 1 567 | ||||||||||||
|
EBIT Million HKD | Released Forecast Spread | 1 060 1 443 -26.55% | 912 1 128 -19.16% | 1 953 2 763 -29.3% | 1 156 1 880 -38.51% | 2 804 3 673 -23.66% | 1 338 2 280 -41.31% | 597 2 325 -74.35% | 1 334 1 744 -23.5% | 3 774 | 2 751 | 1 873 | 1 982 | ||||
|
Earnings before Tax (EBT) Million HKD | Released Forecast Spread | 1 016 1 728 -41.21% | 892 1 203 -25.89% | 1 960 3 236 -39.45% | 1 438 2 221 -35.25% | 3 392 4 041 -16.06% | 1 298 1 719 -24.5% | 574 2 441 -76.48% | 1 309 2 347 -44.22% | 1 768 | 3 080 | 2 653 | 2 755 | ||||
|
Net income Million HKD | Released Forecast Spread | 815 1 372 -40.57% | 589 946 -37.77% | 1 612 2 561 -37.03% | 1 164 1 722 -32.39% | 2 772 1 541 79.93% | 1 055 1 288 -18.04% | 421 2 103 -79.98% | 993 1 849 -46.32% | 1 401 | 2 396 | 2 091 | 2 171 | ||||
|
EPS HKD | Released Forecast Spread | 0,07 0,11 -37.93% | 0,05 0,06 -14.14% | 0,14 0,13 9.05% | 0,10 0,15 -29.61% | 0,09 0,13 -28.05% | 0,04 0,15 -76.01% | 0,09 0,13 -33.2% | 0,36 | 0,33 | 0,18 | 0,13 | 0,13 | 0,13 | 0,13 | ||
| Announcement Date | 15/11/24 | 28/03/25 | 29/05/25 | 22/08/25 | 22/08/25 | 20/11/25 | 25/03/26 | 27/05/26 | - | - | - | - | - | - | - | - |
| 2026-07-31 | Board of Directors Meeting | ||
| 2026-07-31 | Earnings release - Q1 2027 | ||
| 2026-07-31 | Earnings release - Q2 2026 | ||
| 2026-07-31 | Board of Directors Meeting | ||
| 2026-08-01 | Earnings presentation | 04:30 | |
| 2026-08-01 | Earnings release - Q2 2026 | ||
| 2026-08-02 | Earnings release - Q1 2027 | P | |
| 2026-08-02 | Présentation aux Actionnaires / Analystes | ||
| 2026-08-02 | Board of Directors Meeting | ||
| 2026-08-02 | Earnings release - Q1 2027 |
Past sector events for CSPC Pharmaceutical Group Limited
| Today | Earnings presentation | 09:00 | |
| Today | Earnings release - Q2 2026 | ||
| Today | Earnings release - Q1 2027 | ||
| Today | Earnings presentation | 04:30 | |
| Today | Ex-dividend date - 1.57 CNY | 00:00 | |
| Today | Extraordinary General Meeting | 09:00 | |
| Today | Earnings release - Q1 2027 | ||
| Today | Earnings presentation | 03:30 | |
| Today | Ex-dividend date - 36 INR | 00:00 | |
| Today | Ex-dividend date - 10 TWD | 00:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 1093 Stock
- Calendar CSPC Pharmaceutical Group Limited
Select your edition
All financial news and data tailored to specific country editions
















